DIABNEXT ATTENDED THE 11th INTERNATIONAL CONFERENCE ON ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES (ATTD 2018)
Advanced Technologies & Treatments for Diabetes (ATTD) is a unique and innovative conference. The ATTD attracts more than 2,500 participants each year, including leading researchers, clinical practitioners, and industry professionals and companies from around the world to exchange ideas and information on diabetes
“Artificial Intelligence: what impacts on Healthcare?” conference hosting DIABNEXT Executive Chairman Richard Binier HEC 1990 guest speaker
DIABNEXT is launching the first global comprehensive self-management data platform for diabetic patients.
On Monday, October 16th, at the final round of the Diabetes Innovation Challenge in France, the jury of the French Health Insurance
We are thrilled to announce that we are selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit, in Copenhagen, Denmark in November!
DIABNEXT™ the next-generation Diabetes care platform using auto-filled health metrics won on Sept. 19th 2017 the French Grandes Écoles Alumni Association prize in the finals of the French Founder Startup Tour 2017. This innovation challenge, co-organized by French Founders &
DIABNEXT - Our next-generation Diabetes care platform using A.I. and auto-filled health metrics won on Sept. 16th 2018 the Medical Device Company of the Year Trailblazer Gold winner. PM360 is the premier, magazine for marketing decision makers in the pharmaceutical,